このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Ping An Healthcare and Technology 将来の成長

Future 基準チェック /46

Ping An Healthcare and Technology利益と収益がそれぞれ年間40.9%と8.7%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に0.7% 37.2%なると予測されています。

主要情報

40.9%

収益成長率

37.2%

EPS成長率

Consumer Retailing 収益成長	27.4%
収益成長率	8.7%
将来の株主資本利益率	0.7%
アナリストカバレッジ	Good
最終更新日	10 Jun 2024

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

SZSC:1833 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	6,654	93	212	326	10
12/31/2025	6,159	6	28	102	12
12/31/2024	5,362	-195	-262	-291	13
12/31/2023	4,674	-323	-326	-283	N/A
9/30/2023	5,135	-370	-577	-536	N/A
6/30/2023	5,551	-390	-829	-789	N/A
3/31/2023	5,855	-499	-837	-800	N/A
12/31/2022	6,205	-636	-845	-811	N/A
9/30/2022	6,276	-879	-1,042	-992	N/A
6/30/2022	6,347	-1,121	-1,239	-1,174	N/A
3/31/2022	6,841	-1,330	-1,366	-1,288	N/A
12/31/2021	7,334	-1,538	-1,492	-1,403	N/A
9/30/2021	7,636	-1,576	-1,319	-1,232	N/A
6/30/2021	7,938	-1,614	-1,145	-1,060	N/A
3/31/2021	7,402	-1,281	-1,160	-1,081	N/A
12/31/2020	6,866	-948	-1,175	-1,102	N/A
9/30/2020	6,203	-812	-822	-730	N/A
6/30/2020	5,539	-675	-469	-358	N/A
3/31/2020	5,302	-704	-553	-431	N/A
12/31/2019	5,065	-734	-637	-504	N/A
9/30/2019	4,777	-737	-856	-682	N/A
6/30/2019	4,488	-740	-1,075	-859	N/A
3/31/2019	3,913	-826	-1,179	-972	N/A
12/31/2018	3,338	-912	-1,283	-1,085	N/A
9/30/2018	3,082	-1,182	-1,125	-1,007	N/A
6/30/2018	2,542	-990	-866	-827	N/A
3/31/2018	2,205	-996	-681	-655	N/A
12/31/2017	1,868	-1,002	-496	-484	N/A
9/30/2017	1,319	-641	N/A	-531	N/A
12/31/2016	601	-758	N/A	-263	N/A
12/31/2015	279	-324	N/A	-45	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1833は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.2% ) よりも高い成長率であると考えられます。

収益対市場: 1833今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: 1833今後 3 年以内に収益を上げることが予想されます。

収益対市場: 1833の収益 ( 8.7% ) Hong Kong市場 ( 7.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: 1833の収益 ( 8.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1833の自己資本利益率は、3年後には低くなると予測されています ( 0.7 %)。

Ping An Healthcare and Technology 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Forecast breakeven date pushed back to 2026

No longer forecast to breakeven

Forecast to breakeven in 2025

Forecast to breakeven in 2025

No longer forecast to breakeven

Forecast to breakeven in 2024

Recent updates

Forecast breakeven date pushed back to 2026

Ping An Healthcare and Technology Company Limited, Annual General Meeting, Apr 22, 2024

Ping An Healthcare and Technology Company Limited Announces Management Changes

No longer forecast to breakeven

Full year 2023 earnings released: CN¥0.30 loss per share (vs CN¥0.56 loss in FY 2022)

Now 21% undervalued after recent price drop

Ping An Healthcare and Technology Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Ping an Healthcare and Technology Company Limited Announces Board Changes

First half 2023 earnings released: CN¥0.23 loss per share (vs CN¥0.43 loss in 1H 2022)

Ping an Healthcare and Technology Appoints Mr. Li Dou as Non-Executive Director

Ping An Healthcare and Technology Company Limited to Report Q2, 2023 Results on Aug 24, 2023

Forecast to breakeven in 2025

Full year 2022 earnings released: CN¥0.56 loss per share (vs CN¥1.40 loss in FY 2021)

Forecast to breakeven in 2025

Ping An Healthcare and Technology Company Limited to Report Fiscal Year 2022 Results on Feb 13, 2023

Less than half of directors are independent

Ping An Healthcare and Technology Company Limited (SEHK:1833) entered into the equity transfer agreements to acquire Ping An International Smart City Technology Co., Ltd. from Scientia Technologies Limited for $96.8646 million.

Ping An Healthcare and Technology Company Limited (SEHK:1833) entered into the equity transfer agreements to acquire Ping An International Smart City Technology Co., Ltd. from Scientia Technologies Limited for $96.8646 million.

First half 2022 earnings released: CN¥0.39 loss per share (vs CN¥0.80 loss in 1H 2021)

Ping An Healthcare and Technology Company Limited to Report First Half, 2022 Results on Aug 18, 2022

Now 20% undervalued

Less than half of directors are independent

No longer forecast to breakeven

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Forecast to breakeven in 2024

Ping An Healthcare and Technology Company Limited (SEHK:1833) commences an Equity Buyback Plan for 114,729,420 shares, representing 10% of its issued share capital, under the authorization approved on April 21, 2021.

Less than half of directors are independent

Joint Company Secretary Chun Chen has left the company

First half 2021 earnings released: CN¥0.80 loss per share (vs CN¥0.21 loss in 1H 2020)

Non-Executive Director Bo Yao has left the company

Non-Executive Director Fangfang Cai has left the company

Independent Non-Executive Director Xin Liu has left the company

Ping An Healthcare and Technology Company Limited, Annual General Meeting, Apr 21, 2021

New 90-day high: HK$111

Full year 2020 earnings released: CN¥0.92 loss per share (vs CN¥0.73 loss in FY 2019)

Revenue beats expectations

Ping An Healthcare and Technology Company Limited to Report Fiscal Year 2020 Results on Feb 02, 2021

New 90-day low: HK$83.05

New 90-day low: HK$87.10

Ping an Good Doctor and Tsumura (China) Enter into Strategic Cooperation, Internet Healthcare Empowers Chinese Medicine Supply Chain

New 90-day low: HK$88.75

New 90-day low: HK$96.30

Ping an Good Doctor Launches Multi-Layered Membership System

New 90-day low: HK$99.25

Ping an Healthcare and Technology Company Limited Announces Launch of Ping an Doctor Home

First half earnings released

Ping An Healthcare and Technology Company Limited to Report First Half, 2020 Results on Aug 20, 2020

New 90-day high - HK$129

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘